Close Menu

NEW YORK – Stratify Genomics said on Monday that it has partnered with PWNHealth to offer Stratify's prostate cancer genetic risk test directly to consumers with medical oversight.

Specifically, Stratify and PWNHealth will provide clinical oversight and patient support for Stratify's Prompt Personal Genetic Score (PGS) through the Stratify online portal.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.